1,027
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

The effect of rural and urban life on peritonitis rates in chronic peritoneal patients

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2163504 | Received 26 Jul 2022, Accepted 22 Dec 2022, Published online: 16 Jan 2023

Abstract

Background

It has been reported that living far from the peritoneal dialysis (PD) unit is a risk factor for peritonitis. Considering that PD units are urban located; the question of whether living in a rural area compared to an urban area is a risk factor for peritonitis has arisen.

Methods

From March 2010 to August 2020, 335 episodes of peritonitis in 202 PD patients followed in a single center were evaluated retrospectively. People living in areas with a population <1000 were defined as living in rural areas regardless of their distance from the PD center. Cox regression analysis was used to identify independent factors associated with peritonitis.

Results

A total of 202 PD patients were followed during 791 patient-years (mean follow-up of 3.9 years per patient). Total patients had 335 episodes of peritonitis and the rate of peritonitis was 0.42 episodes per year (episodes/patient-year). Cox regression analysis revealed that living environment (urban vs. rural) was not a risk factor for peritonitis (p = 0.57).

Conclusions

In Turkey, we report that living in a rural area in our region is not a risk factor for peritonitis. It is not the right approach for both the physician and the patient to be reluctant in the choice of PD due to the concern of peritonitis in rural areas.

Introduction

Peritoneal dialysis (PD) is applied as renal replacement therapy (RRT) at a rate of approximately 11% over the world [Citation1]. Peritonitis remains one of the most serious and life-threatening complications of PD. Besides that, ultrafiltration loss and permanent peritoneal membrane damage are closely related to the necessity of removing the catheter, which leads to technical failure and hemodialysis (HD) conversion [Citation2].

In Turkey, 4.06% (n: 3387) of the patients receiving RRT perform PD. RRT starts with PD in approximately 10% (1200) of patients every year [Citation3].

In the guideline published by the International Society of Peritoneal Dialysis (ISPD) in 2022, both the prevention and treatment of peritonitis are at the forefront. Risk factors in peritonitis associated with PD are divided into two groups non-modifiable and modifiable [Citation4]. Living far from the PD unit in the modifiable group is one of them [Citation5]. Considering that the PD units are located in urban areas, the question of whether living in a rural area is a risk factor for peritonitis was brought to mind. In addition, the desire to choose PD has increased due to the problems in the accessibility to HD in the rural patient group. However, the fact that living away from the PD unit increases the risk of peritonitis may cause physicians to hesitate about initiating PD in this patient group. We believe that more studies are needed; since there are few about that subject, to answer whether living away from the PD unit as well as living in rural and urban areas is a risk factor independent of distance.

Material and methods

A total of 202 (with and without peritonitis) patients were evaluated. Between March 2010 and August 2020, 335 episodes of peritonitis in 202 patients who have undergone PD treatment and were followed up by our clinic were evaluated retrospectively. It was a single-center study. Our center was the only actively-serving center in eastern Turkey. The patients were followed up with the same nurse group (two nurses). The patients were trained regardless of the duration by the same nurses in a way that they and their assistants would perform PD, and PD was started. Approval was obtained from the local ethics committee. Since it was a retrospective observational study, patient consent was not required. Peritonitis was diagnosed according to peritoneal dialysis (ISPD) guidelines 2022 International Society, at least two of the following criteria were required: clinical features consistent with peritonitis, that was abdominal pain and/or cloudy dialysis effluent, dialysis effluent white cell count >100/mL or >0.1 × 109/L (after a dwell time of at least 2 h), with >50% polymorphonuclear leukocytes (PMN), positive dialysis effluent culture [Citation6]. Gram stain, culture, Mycobacterium Tuberculosis culture and staining, and fungal cultures were routinely requested from all patients presenting with peritonitis episodes. All patients diagnosed with peritonitis were followed up in our center until culture results were obtained. Overall peritonitis rate calculation included all peritonitis events, not just the first peritonitis event. Living in rural and urban areas was determined from addresses in the hospital registration system. Rural living areas were those living in hamlets, villages, and towns connected to districts and central districts (). The definition of the rural area was taken as those living in areas with a population <1000. Although their distance to the PD center was not assessed, the nearest rural area to the PD center was over 30 km. The study population was ethnically homogeneous and of Caucasian descent. The peritonitis rate in urban and rural areas was calculated as the annual number of attacks (episodes per patient/years) recommended by ISPD 2016 (2). However, some of the socio-demographic (educational status, heating type of the house, marital status, number of people living at home, type of construction of the house, whether they use a separate area for PD, whether they use an assistant for PD, etc.) characteristics of the patients were also examined.

PD modalities

At PD initiation, participants were assigned to one of the PD modalities; CAPD with a twin-bagged system or instrumented peritoneal dialysis (IPD) (6–8 h with 6–10 l). The prescription of CAPD was 4 × 1.5–2 L (body surface area, RRF determined) exchanges as long as no sign of inadequate dialysis was observed. Dialysate fluids containing (i) 1.36%, 2.27%, or 3.86% glucose; (ii) amino acids; or (iii) icodextrin were used according to the clinical needs of patients.

Statistical analysis

SPSS version 20.0 (IBM Cor., Chicago, IL) program was used for data analysis. In the statistical analysis of the study, mean, standard deviation, frequency, and percentage values were defined. The general characteristics and demographic characteristics of the groups were determined by frequency (descriptive analysis: frequency analysis for a single variable) analysis. In pairwise comparisons; independent Samples t-Test was used to compare the mean of two independent groups. The Chi-square test was used to determine the relationship between categorical variables. A p ≤ 0.05 value was considered statistically significant in the entire study.

The endpoint for the peritonitis-free survival analysis of the patients was the first episode of peritonitis. Peritonitis-free survival analysis of rural and urban patient groups was calculated by Kaplan–Meier method using Log-rank test for p value.

During the follow-up period of patients continuing PD, in order to determine the risk factors of peritonitis at any time, a model was created with patients being the dependent variables; living environment (rural and urban) was evaluated as a univariate variable, and gender, age, marital status, living environment (rural and urban), number of people living in the same house, type of house structure, type of house heating, education level, diagnosis for diabetes mellitus, diagnosis for hypertension, PD method, history of HD, preference reason for PD, PD practitioner, presence of reserved room, and use of bathroom tape were evaluated as multivariate variables of the independent variables. Cox regression analysis was performed on the determined model. All tests were bidirectional. Confidence intervals of 5% are given for the risk of type I error. The study sample was determined as 141 using the PASS version 15 program (Kaysville, Utah) by taking hazard ratio 1.2, α = 0.05, power (1–β) = 0.90 confidence level. A total of 202 were reached. A p ≤ 0.05 value was considered statistically significant in the entire study.

Results

A total of 202 PD patients were followed during 791 patient-years (mean follow-up of 3.9 years per patient). Patients experienced a total of 335 episodes of peritonitis and 0.42 episodes per patient-year of treatment. While 60 (30%) of the examined patients lived in rural areas, 142 (70%) patients lived in urban areas. Of the patients in the rural area, 29 (48.3%) were female and 31 (51.7%) were male. Of the patients in the urban area, 66 (46.5%) were female and 76 (53.5%) were male. There was no difference between the mean age of patients living in rural areas and patients living in urban areas (51.55 ± 16.117, 54.75 ± 15.528, respectively). Other characteristics are presented in .

Table 1. Demographic and other characteristics of people living in rural and urban areas.

Bacterial peritonitis was detected in 287 (85.7%) and fungal peritonitis was detected in 10 (3%) of the patients, while no growth or contamination was detected in the cultures of the remaining 38 cases (11.3%). When the causative microorganisms of bacterial peritonitis were examined, Methicillin-sensitive coagulase-negative staphylococci (MSCNS) were found in the first place with 30.9%, and methicillin-resistant coagulase-negative staphylococci (MRCNS) were found in the second place with 17.1%. These were followed by Staphylococcus aureus, Escherichia coli, and enterococci, respectively. The most common cause of fungal peritonitis was found to be Candida parapsilosis and Candida albicans. Mycobacterium tuberculosis was detected in only two patients. There was no difference in cultural results between those living in rural and urban areas.

The proportion of those who never experienced peritonitis was higher in the urban area (43.7 vs. 25%) (). In addition to this, there were differences between the groups, such as education level, the structure of the house they lived in, the way the house was heated, the reason for the preference for PD, and the presence of a room reserved for PD. There was no statistically significant difference between the time to the first peritonitis attack (rural = 24.33 ± 20.905 months and urban = 23.33 ± 25.173 months) (p = 0.301) and patient peritonitis rates (rural = 0.61 ± 0.749 and urban = 0.49 ± 0.737) (p = 0.256) ().

When we examine only the patients who experienced peritonitis living in urban and rural areas; the peritonitis rate of the urban group was 0.86 episodes per year, while the peritonitis rate of the patients living in rural areas was 0.82 episodes per year (p = 0.772). The differences between rural and urban residents with peritonitis were educational status, type of heating structure of the house, having a separate room for PD, and the rate of PD out of necessity ().

Table 2. Demographic and other characteristics of patients with peritonitis who are living in urban and rural areas.

In the analysis made by Kaplan–Maier method between rural and urban groups; no statistically significant difference was found for peritonitis-free survival (Log-rank p = 0.561) ().

Figure 1. Kaplan–Meier analysis of peritonitis-free survival: comparison of rural and urban patient groups.

Figure 1. Kaplan–Meier analysis of peritonitis-free survival: comparison of rural and urban patient groups.

Figure 2. Erzurum center, districts, and neighboring provinces map (the only peritoneal center in this region (

,
; urban areas).

Figure 2. Erzurum center, districts, and neighboring provinces map (the only peritoneal center in this region (Display full size, Display full size; urban areas).

By univariate Cox regression analysis, living in rural areas does not increase the risk of peritonitis (). When we evaluated the factors affecting peritonitis in PD in Multivariate Cox-regression analysis, it was observed that social and demographic characteristics such as living in a rural environment, having a separate room for PD, the type of structure of the house, the heating type of the house, educational status, number of people living in the house, marital status did not have an effect ().

Table 3. Results of Cox-regression analysis of peritoneal dialysis patients affecting peritonitis.

Discussion

With the Progressive Kidney Health Initiative’s report in 2019, there is a new push for home dialysis in the United States, with the goal that 80% of new patients with kidney failure will receive home dialysis or kidney transplantation by 2025 [Citation7]. A study by American nephrologists found that distances of >50 km between the patient’s residence and the dialysis facility had a significant impact on the choice of modality. With the ability to monitor treatments remotely and make monthly clinic visits, a home dialysis is a convenient option for patients who do not live near a dialysis unit. This is especially valid in rural areas. Studies have reported that peritoneal patients mostly live in rural areas [Citation8–10]. Therefore, it was important to evaluate the relationship between PD and peritonitis, the most important cause of mortality and morbidity in rural areas. This study is one of the rare studies performed on how the life differences of PD patients in rural areas will affect peritonitis. Our peritonitis patient-year rate at our center was 0.42. There is great variation in the rates of PD peritonitis between different centers and countries. Reported rates range from 0.06 to 1.66 episodes/patient-year [Citation4]. Our PD peritonitis culture-negative rate was per the ISPD recommended rate of less than 15% of acceptable culture-negative peritonitis episodes [Citation2].

PD patients living in rural areas had a similar rate of peritonitis and a lower rate of patients without peritonitis. Studies have generally emphasized the relationship between living far from the PD center and peritonitis [Citation5,Citation11]. It is reported that living far from the PD center increases the risk of peritonitis. In addition, some studies estimated that the high rate of peritonitis in those living close to the PD center may have reflected worse hygiene conditions in urban environments [Citation12]. Living far from the PD center has been associated with the risk of peritonitis in a short span of time [Citation5]. The low rate of patients without peritonitis in rural areas in our study supports this. Manish M Sood et al. in the study they performed, reported that there was no significant difference in terms of peritonitis among aboriginals (61 patients in total) living in rural and urban areas [Citation13]. The low number of cases may not have revealed the difference in this regard. In studies conducted on this subject, it may be possible to obtain contradictory results due to geographical differences, ethnic origin, and socio-cultural and economic differences in urban and rural areas. There was no ethnic difference in our study. All our patients who experienced peritonitis were given standard training by the same PD training nurse, and our training was repeated after each peritonitis episode. In addition, the education level of PD patients living in rural areas was lower than patients living in urban areas. For this reason, standard training may not be sufficient for patients living in rural areas. Compared to PD patients from urban settings, PD patients living in rural areas had a higher rate of developing at least 1 peritonitis episode and a lower rate of never developing peritonitis. This may be due to repetitive training. It is known that PD education in patients is especially important for peritonitis [Citation14]. In addition, developing and increasing educational tools and trainers may contribute to the decrease in peritonitis rates compared to previous years [Citation15]. It was found that only 74% of PD patients performed the PD procedure correctly in terms of infection prophylaxis. Based on this result and an assessment of the knowledge of 353 patients who completed a questionnaire, the authors estimated that 29% of patients needed retraining of the PD replacement technique. In addition, an observational study in Italy showed that hospitals that provided retraining to PD patients had lower rates of peritonitis than those that did not [Citation16,Citation17]. Therefore, we believe that it would be beneficial to individualize PD training according to the patient. In the study performed by Martin LC et al. [Citation12], they reported that the training level of the patients may be an important risk factor for peritonitis. In addition, there is no evidence that the risk of peritonitis is related to when, where, how and for how long PD patients should be educated. PD patient education supports that PD can be delivered in any way that is compatible with locally available resources and individualized to the needs of the patient [Citation18].

In the microbiological examination of our patient group, the most common agent was Coagulase-negative Staphylococci. It was similar to the studies performed [Citation2,Citation19]. In addition, publications are reporting that Staphylococcus aureus is the most common factor in patients living far from the PD center [Citation5,Citation11]. Nasal colonization has been reported to be an important factor, and the use of mupirocin has been shown to reduce the rate of peritonitis [Citation5,Citation20,Citation21]. The reason why it was not in the top ranks in our study may be that nasal colonization was investigated and treated at the beginning of PD.

Conclusion

In PD, social life and demographic differences of rural residents are not a parameter affecting the rate of peritonitis in our region. It is not the right approach for both the physician and the patient to be reluctant in the choice of PD due to the concern of peritonitis in rural areas.

Study limitations

There were strengths and limitations in our study. Being a large PD center in this region with over 30 years of PD experience in the east of Turkey, presenting the experiences of a center with a different geographical location to the literature, homogeneity of our patient group, and making social contributions were our strengths. The limitations of our study were that our patient group was limited.

Ethical approval

All participants gave informed consent and the local institutional ethics committee approved the study methods (Ethical Box. No: B.30.2 AT;0.01.00/12) ‘Declarations Section’– ‘Ethics approval and consent to participate’ sub-section.

Author contributions

ERDEM ÇANKAYA, MURAT ALTUNOK AYCAN MUTLU YAĞANOĞLU: Conceptualization, Methodology, Software, Data curation, Writing – Original draft preparation. Visualization, Investigation. Supervision Software, Validation. Writing – Reviewing and Editing.

Acknowledgments

Applicable.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The datasets generated during and/or analyzed during this study are not publicly available but are available from the corresponding author on reasonable request.

Additional information

Funding

The authors report no involvement in the research by the sponsor that could have influenced the outcome of this work.

References

  • Struijk DG. Peritoneal dialysis in Western countries. Kidney Dis (Basel). 2015;1(3):157–164.
  • Liakopoulos V, Nikitidou O, Kalathas T, et al. Peritoneal dialysis-related infections recommendations: 2016 update. What is new? Int Urol Nephrol. 2017;49(12):2177–2184.
  • Turkish Society of Nephrology Registry Committee. Registry of the nephrology, dialysis and transplantation in Turkey registry 2020. Ankara. 2021;1–178. http://www.nefroloji.org.tr/folders/file/REGISTRY_2020.pdf
  • Cho Y, Johnson DW. Peritoneal dialysis–related peritonitis: towards improving. Evidence, practices, and outcomes. Am J Kidney Dis. 2014;64(2):278–289.
  • Cho Y, Badve SV, Hawley CM, et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-Centre registry study. BMC Nephrol. 2012;13:41.
  • Li PK, Cho KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153.
  • US Department of Health and Human Services: Advancing American Kidney Health. [accessed April 16, 2021]. Available from: https://aspe.hhs.gov/system/files/pdf/262046/AdvancingAmericanKidneyHealth.pdf
  • Mendelssohn DC, Mullaney SR, Jung B, et al. What do American nephrologists think about dialysis modality selection? Am J Kidney Dis. 2001;37(1):22–29.
  • O'Hare AM, Johansen KL, Rodriguez RA. Dialysis and kidney transplantation among patients living in rural areas of the United States. Kidney Int. 2006;69(2):343–349.
  • Pattharanitima P, El Shamy O, Chauhan K, et al. The association between prevalence of peritoneal dialysis versus hemodialysis and patients’ distance to Dialysis-Providing facilities. Kidney360. 2021;2(12):1908–1916.
  • Gray NA, Grace BS, McDonald SP. Peritoneal dialysis in rural Australia. Nephrology. 2013;14:278.
  • Martin LC, Caramori JC, Fernandes N, et al. Geographic and educational factors and risk of the first peritonitis episode in Brazilian peritoneal dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol. 2011;6(8):1944–1951.
  • Sood MM, Komenda P, Sood AR, et al. Adverse outcomes among aboriginal patients receiving peritoneal dialysis. CMAJ. 2010;182(13):1433–1439.
  • Chow KM, Szeto CC, Law MC, et al. Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol. 2007;2(4):647–652.
  • Piraino B. Innovations in treatment delivery, risk of peritonitis, and patient retention on peritoneal dialysis. Semin Dial. 2017;30(2):158–163.
  • Russo R, Manili L, Tiraboschi G, et al. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int Suppl. 2006;70:127–132.
  • Bordin G, Casati M, Sicolo N, et al. Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care. 2007;33(4):165–171.
  • Cheetham MS, Zhao J, McCullough K, et al. International peritoneal dialysis training practices and the risk of peritonitis. Nephrol Dial Transplant. 2022;37(5):937–949.
  • Kitterer D, Latus J, Pohlmann C, et al. Microbiological surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in Germany over 32 years. PLoS One. 2015;10(9):e0135969.
  • Davenport A, Pan Thames Renal Audit Peritoneal Dialysis Group. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The pan Thames renal audit. J Nephrol. 2012;25(5):819–824.
  • Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients udergoing peritoneal dialysis. Nephrol Dial Transplant. 2010;25(2):587–592.